Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Novo Nordisk leads the sector in spending on shareholder enrichment: With a ratio of 1.41, Novo Nordisk spent 41% more on shareholder returns (buybacks and dividends) compared to R&D, making it the highest spender on shareholder enrichment among 15 peer companies 9 in the pharmaceutical sector
Find your medicine Search for your prescribed medicine using the search bar
C., Sarwer, D
GLP-1 medications are capable of changing the way the digestive system works
US$ 25.70
US$ 23.85
US$ 29.54
US$ 29.94
US$ 22.82
